Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

HerStory exhibit celebrates Int’l Women’s Month

Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

• CHRYSEE G. SAMILLANO

EXHIBIT. Wen Quilisadio, Bodie Lamela, Atty. Andrea Si, Sugar Tonogbanua and Michelle Ledesma (l-r) at the opening of “HerStory” art exhibition at the Ayala Malls Capitol Central on March 18*

A group art exhibition, in celebration of International Women’s Month, opened at the ground floor of Ayala Malls Capitol Central on March 18 and will run until March 31.

Titled “HerStory”, the show was organized by Ayala Malls in partnership with Mixlada Art Group and Artisticrew, and features the works of about 42 Negrense artists.

Guest of honor at the opening was Andrea Lizares-Si, chair of the Provincial Council for Women. She was joined by Bodie Lamela and Michelle Ledesma, Ayala senior operations associate and Ayala marketing associate, respectively.

Sugar Tonogbanua, Andrea Si, February Cheryl, Mari Zayco and Patty Ong (l-r)*
February Cheryl, Sugar Tonogbanua, Patty Ong, former Talisay mayor Dr. Eric Saratan and Mari Zayco (l-r)*
The participating artists with their guests*

The National Women’s Month Celebration has its roots in the recognition of International Women’s Day (IWD) on March 8th, a historical event stemming from the organizing efforts of women in the early 20th Century.

The 2024 National Women’s Month Celebration aims to capitalize on the recurring theme “WE for gender equality and inclusive society,” introduced in 2023. This theme, launched to renew commitment to the advocacy, builds upon the accomplishments under the 2016-2022 theme, “WE Make CHANGE Work for Women.” The earlier theme stressed the importance of compassionate and harmonized networks towards gender equality and women’s empowerment (GEWE).*

ARCHIVES

Read Article by date

July 2024
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
293031 

Get your copy of the Visayan Daily Star everyday!

Avail of the FREE 30-day trial.